Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Manufacture Advanced Medicine, Drug Discovery

Transgenic Drug Discovery

What’s the story behind Crescendo Biologics?

Crescendo Biologics is a spinout created using IP originally generated at the Babraham Institute in Cambridge, UK, funded by the Biotechnology and Biological Sciences Research Council. Prior to the formation of Crescendo, a research group led by Marianne Bruggemann laid the foundations for highly successful transgenic mice capable of generating fully human antibodies.

Part of what makes mAb-based therapeutics so successful is their superb binding specificity, but constraints imposed by their shape and size mean there are important therapeutic targets and indications that regular mAbs cannot address. Regular mAbs comprise two paired peptide chains – a heavy and light chain (H and L respectively). However, camels and llamas naturally produce a stable class of antibodies that lack the light-chain. These heavy-chain antibodies (HcAbs) contain the smallest unit of an antibody known to recognize and bind to its therapeutic target – the so-called VHH domain. Although camel-derived VHH molecules are a step towards creating the next generation of therapeutics that could address the shortcomings of mAbs, they are not ideal: 1) VHH are not “human” in origin and as such, are likely to be immunogenic when injected into humans; and 2) due to their structural adaptation, VHH are limited in their diversity, reducing the likelihood of successful outcomes in drug discovery.

An important paper published by Marianne’s group in 2007 observed that mice engineered to lack the ability to create antibody L-chains were able to spontaneously, albeit very inefficiently, generate their own HcAbs.

From this concept, Crescendo was born.

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!


Or register now - it’s free!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

When you click “Register” we will email you a link, which you must click to verify the email address above and activate your account. If you do not receive this email, please contact us at [email protected].

About the Author

Stephanie Sutton

Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent seven years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine